Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07009704 · ClinicalTrials.gov registry record · NA

Glucose Empowerment Through Monitoring and Social Support in Pregnancy

A NA study of Gestational Diabetes and Pregnancy Complications, sponsored by Tufts Medical Center.

Recruiting
Registry status
NA
Development phase
70
Enrollment target
1
Study location

NCT07009704: Recruiting NA study of Gestational Diabetes and Pregnancy Complications, sponsored by Tufts Medical Center.

NCT07009704 is a NA study of Gestational Diabetes and Pregnancy Complications that is actively recruiting participants, run by Tufts Medical Center. The registered enrollment target is 70 participants, below the 320-participant average among 41 other Gestational Diabetes trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07009704, a NA study of Gestational Diabetes and Pregnancy Complications, is actively recruiting participants, sponsored by Tufts Medical Center.

RECRUITING
Registry status
NA
Development phase
70 participants
Enrollment target
1
Study location

Study Summary

The purpose of the research is to learn whether wearing a continuous glucose monitor that shows blood glucose levels in real time on a smart phone app and participating in a group chat with other research participants will help participants keep a healthy blood glucose level during pregnancy. High levels of blood glucose during pregnancy can lead to health problems during and after pregnancy. It may also increase the risk for health problems for the developing baby. The investigators think our program might be a new way to help some people maintain a healthy blood glucose level during pregnancy. When pregnant people know their blood glucose levels are high, they can do things like exercise or drink water to bring their blood glucose levels down. They can also learn what foods to eat to maintain healthy blood glucose levels, and what foods to avoid. The investigators think being in a group chat with other pregnant individuals will allow participants to support and learn from each other. Pregnant individuals should also work with their healthcare providers to manage their blood glucose levels.

Primary Outcome

Self-efficacy will be adapted from a validated survey of self-efficacy for type II diabetes management (DMSES UK)

Interventions

  • BEHAVIORAL Mobile-based social support
  • BEHAVIORAL Real-time continuous glucose monitoring

Study Locations (1)

Massachusetts

  • Tufts Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2025-07-01
Est. Completion 2026-07
Phase NA
Tufts Medical Center

169 total trials

What NCT07009704 shows while recruiting

NCT07009704 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 320-participant average among 41 other Gestational Diabetes trials with a reported enrollment target (78% lower).

The record links to 2 conditions, with Gestational Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Mobile-based social support is the first listed.

NCT07009704 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT07009704 about?

NCT07009704 is a clinical study titled "Glucose Empowerment Through Monitoring and Social Support in Pregnancy". The purpose of the research is to learn whether wearing a continuous glucose monitor that shows blood glucose levels in real time on a smart phone app and participating in a group chat with other research participants will help participants keep a healthy blood glucose level during pregnancy. High ...

What is the current status of trial NCT07009704?

This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2025-07-01. Estimated completion is 2026-07.

What conditions does trial NCT07009704 study?

This clinical trial studies the following conditions: Gestational Diabetes, Pregnancy Complications.

What interventions are being tested in trial NCT07009704?

The interventions under investigation include: Mobile-based social support (BEHAVIORAL), Real-time continuous glucose monitoring (BEHAVIORAL).

Who is sponsoring clinical trial NCT07009704?

This trial is sponsored by Tufts Medical Center, which has 169 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07009704 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gestational Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07009704's enrollment target sits among peer trials

70 26th of 41 higher than 16 of 41 other Gestational Diabetes trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Gestational Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00969111 · 70 participants · NA

    Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

  • NCT01712620 · 70 participants · Phase 2

    Spironolactone for Pulmonary Arterial Hypertension

  • NCT02143830 · 70 participants · Phase 2

    HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy

  • NCT02601339 · 70 participants

    NIRS Monitoring in Premature Infants

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07009704, the US trial registry maintained by the National Library of Medicine. NCT07009704 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.